FGF2, SMOC1 and TIMP2 were chosen for IHC testing, as these genes had markedly increased RNA expression levels in BPH relative to controls, and antibodies were available that produced specific and satisfactory staining of human TZ tissues. Here, TIMP2 is linked to benign prostatic hyperplasia.